Call it the yin and yang of the biopharmaceutical industry. Good news for one company is nearly always bad news for another. Zogenix (NASDAQ: ZGNX) announced very good news last week. Its experimental drug ZX008 proved to be …
On Friday, shares of pharmaceutical company Zogenix Inc. ZGNX are skyrocketing, and as of 1:05 PM EST, the stock is trading up over 171% to $34.90 per share. ZGNX closed the day on Thursday at $12.88 per share, meaning the small …
[ibd-display-video id=2325457 width=50 float=left autostart=true]By the closing bell on the stock market today, Zogenix had surged 11% to finish at 38.90, after earlier rising as much as 18.8% to touch a high last seen in March 2011. …
Nasdaq6mon
If you want a Stock Review on IMNP, ZGNX, SHPG, or ABBV then come over to http://dailystocktracker.com/register …
(Reuters) - Zogenix Inc’s experimental treatment for a rare form of epilepsy met the main goal in a late-stage study, the company said on Friday, more than doubling the value of its shares and hurting those of peer GW Pharmaceuticals . In …
I wrote in August that Zogenix was a biotech stock that could soar in September. And it did. Zogenix stock more than doubled on Friday after announcing very good results from a late-stage study of experimental drug ZX008 in treating …
Investors in Zogenix, Inc. ZGNX need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20, 2017 $2 Put had some of the highest implied volatility of all equity options today. What …
Investors in Zogenix, Inc. ZGNX need to pay close attention to the stock based on moves in the options market lately. That is because the September 15th, 2017 $6 Put had some of the highest implied volatility of all equity options today. …